Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global infusion pump market was valued at US$ 9.56 billion in 2021 and is expected to register a revenue CAGR of 7.10% to reach US$ 17.7 billion by 2030.

Infusion Pump Market Fundamentals 

An infusion pump is a medical device used for the controlled administration of fluids to patients. Infusion pumps are available in various types and are employed in different therapeutic areas, such as diabetes, cancer treatment, and nutrition delivery. Infusion pumps can deliver fluids in large or small quantities and can be used to administer nutrients or medications such as antibiotics, chemotherapy drugs, insulin or other hormones, and painkillers. Some infusion pumps are primarily intended for stationary usage at the patient’s bedside. Ambulatory infusion pumps are wearable or portable.

[72487932]

Infusion Pump Market Dynamics

The global infusion pump market is projected to register revenue growth at a significant pace during the forecast period owing to increasing cases of chronic diseases, such as diabetes, cancer, and arthritis. Furthermore, technological advancements and increase in product launches contribute to the revenue growth of the global infusion pump market. Moreover, growing geriatric population, increasing demand for infusion pumps in the homecare segment, and rising number of companies entering in the production of infusion pumps are fueling revenue growth in the global infusion pump market.

However, stringent regulations and protocols associated with product approvals, high cost of infusion pumps, and growing demand for refurbished devices are likely to hinder the revenue growth in the global infusion pump market.

Infusion Pump Market Ecosystem

The global infusion pump market is analyzed based on four parameters: type, application, end user, and region. 

Infusion Pump Market by Type

Based on the type, the global infusion pump market is segmented into volumetric pumps, syringe pumps, enteral pumps, insulin pumps, elastomeric pumps, implantable pumps, and others. 

The insulin pump segment dominates the infusion pump market with high revenue share owing to technological advancements, increase in number of product launches, and rise in the acquisition and merger activities among the leading product manufacturers. Moreover, insulin pumps offer improved therapeutic control than insulin pens, high accuracy of dose, enhanced blood glucose monitoring, and good management of HbA1c levels. These advantages of the product are resulting into their increased adoption, which in turn, is fueling revenue growth in the segment.

Infusion Pump Market by Application

[43255234]

Based on the applications, the global infusion pump market is segmented into diabetes, oncology, pain management, and others. 

The diabetes pump segment is leading the global infusion pump market in terms of revenue share owing to increasing geriatric population with type 2 diabetes, rising awareness about diabetes, and availability of affordable diabetes diagnostics. Additionally, increasing government initiatives for diabetes management and rising adoption of insulin pumps are contributing to the revenue growth of the global diabetes infusion pump market. According to the International Diabetes Federation, 783 million individuals are likely to be diagnosed with diabetes by 2045, about 537 million adults had diabetes and around 6.7 million individuals died due to diabetes in 2021. 

The oncology infusion pump segment is also expected to register exceptional revenue growth during the forecast period owing to increasing cancer cases and rising R&D activities.

Infusion Pump Market by End User

Based on the end user, the global infusion pump market is segmented into hospitals & clinics, ambulatory care, home care, and others. 

The hospitals & clinics segment is leading the global infusion pump market owing to rising chronic diseases and increasing patient footfall for diagnosis and treatment of these diseases. Additionally, increasing adoption of the infusion pump and availability of favorable reimbursement policies in hospitals and clinics are contributing to the revenue growth of the segment.

Infusion Pump Market by Region

Based on the region, the global infusion pump market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). 

North America dominates the global infusion pump market in terms of revenue share. The large revenue share of North America in the global market is attributed to increasing cases of chronic diseases, rising adoption of novel technologies, and growing number of regulatory-approved infusion pumps. Additionally, favorable reimbursement policies, developed infrastructure, and presence of several key players are fueling the infusion pump market revenue growth in North America.

Infusion Pump Market Competitive Landscape

The prominent players operating in the global infusion pump market are:

• B. Braun Melsungen AG 
• Baxter 
• Becton Dickinson and Company
• F. Hoffmann-La Roche Ltd 
• Fresenius Kabi AG 
• ICU Medical, Inc.
• Insulet Corporation
• Medtronic
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd
• Smith’s Medical 
• Terumo Corporation 

Infusion Pump Market Strategic Developments

• In Aug 2022, Baxter International Inc. announced that it received clearance from the U.S. Food and Drug Administration (FDA) 510(k) for its new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, representing Baxter’s latest developments for infusion therapy. The Novum IQ SYR provides a technologically integrated user experience with enhanced safety features, advanced connectivity, configurable anesthesia care settings, and a strong portfolio of sets designed to help deliver optimum accuracy.
• In September 2021, Medtronic acquired novel implanted infusion pump technology for type 1 diabetes therapy. The technology distinguishes itself from other implanted pumps by improving insulin delivery precision and providing MRI compatibility and occlusion detection. Despite these improvements, the resulting pumps are smaller and lighter than many other insulin pumps in the market today.

Frequently Asked Questions About This Report